6505--Ramipril Capsules RFP
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0034
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
-
Additional Details
Documents1
The Department of Veterans Affairs (VA) National Acquisition Center (NAC) has issued a presolicitation notice for an upcoming Request for Proposal (RFP), procurement identifier 36E79726R0034, concerning the supply of Ramipril capsules. This procurement is intended to secure an uninterrupted supply of Ramipril capsules for multiple federal agencies, including the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will be awarded to a responsible offeror capable of meeting the requirements for continuous supply and distribution.
The scope of this procurement encompasses the manufacturing and delivery of Ramipril capsules in various strengths and packaging sizes. The estimated annual requirements are as follows:
- Ramipril 1.25mg capsules, 100-count bottles: 2,930 units
- Ramipril 2.5mg capsules, 100-count bottles: 2,498 units
- Ramipril 2.5mg capsules, 500-count bottles: 1,611 units
- Ramipril 5mg capsules, 100-count bottles: 6,018 units
- Ramipril 5mg capsules, 500-count bottles: 2,704 units
- Ramipril 10mg capsules, 100-count bottles: 15,956 units
- Ramipril 10mg capsules, 500-count bottles: 4,451 units
The contract period will be for one year, with four pre-priced one-year option periods, allowing for a potential total contract duration of five years. Distribution of the contracted items will occur through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs, ensuring efficient and reliable delivery to the end users.
Key requirements for offerors include:
- The exact name of the drug as it appears on the label must be stated in the proposal.
- Each product must have a unique National Drug Code (NDC) number.
- Glass bottles are not acceptable for packaging; only non-glass containers will be considered.
The procurement is classified under NAICS code 325412, Pharmaceutical Preparation Manufacturing (2022 version), and is unrestricted, meaning it is open to all responsible sources. The solicitation will be issued electronically in commercial item format in accordance with FAR Part 12, with no paper copies available. Offerors are advised to monitor the official solicitation page (https://sam.gov/opp/dfb4dcac249c49929a568cd556ed5f9d/view) for amendments and updates.
The contracting entity is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is Amber Zavala, who can be reached via email at [email protected] or by phone at (708) 786-5245.
The anticipated issue date for the solicitation is November 16, 2026, with a tentative closing date of November 30, 2026. Interested offerors should ensure timely submission of proposals and direct any questions to the designated contact.
This opportunity represents a significant and stable contract for pharmaceutical manufacturers capable of supplying Ramipril capsules in compliance with federal requirements and distribution protocols. Contractors should carefully review the requirements and ensure their capabilities align with the scope and objectives outlined in the presolicitation notice.